openPR Logo
Press release

Rectal Cancer Therapeutics Pipeline Review 2018 - Taiwan Liposome Company, Sanofi and Advaxis, Inc.

10-26-2018 08:29 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Rectal Cancer Therapeutics Pipeline Review 2018 - Taiwan

According to the research findings, most of the drug candidates for the treatment of rectal cancer are being developed to be administered by the intravenous and the oral route. The main advantage associated with the intravenous route is that the drug can easily be entered the bloodstream, or lymph vessels. Also, medication can be easy to take through the oral route, additionally the route has very less patient non-compliance.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/rectal-cancer-therapeutics-pipeline-analysis/report-sample

It has been observed that most of the therapeutics that are being developed for acting on the specific target, and interventional studies including targeted therapeutics for the treatment of rectal cancer, have showed positive efficacy in the clinical as well as Pre-Clinical stage of development. An example of such therapy includes, Ziv-aflibercept, a fusion protein, under the Phase II stage of development by Sanofi S.A. for the treatment of rectal cancer. Ziv-aflibercept has been approved by USFDA for use in combination with 5-fluorouracil, leucovorin, and irinotecan in patients with metastatic colorectal cancer and rectal cancer.

It has been observed that, rise in geriatric population and increasing incidence of rectal cancer has been driving the growth of the rectal cancer pipeline. Colorectal cancer includes both colon and rectal cancers. According to the National Cancer Institute, in 2017, the incident cases of colorectal cancer were found as 40.1 per 100,000 people per year. The increasing geriatric population is mostly frail and unable to tolerate the treatments such as radiation therapy and chemotherapy for the treatment of cancer. This is one of the most prominent factor due to which companies are focusing towards development of therapeutics for the treatment of rectal cancer.

Browse report at: https://www.psmarketresearch.com/market-analysis/rectal-cancer-therapeutics-pipeline-analysis

Some of the key players involved in the development of rectal cancer therapeutics include Taiwan Liposome Company, Sanofi and Advaxis Inc.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rectal Cancer Therapeutics Pipeline Review 2018 - Taiwan Liposome Company, Sanofi and Advaxis, Inc. here

News-ID: 1330476 • Views: 316

More Releases from P&S Intelligence

Data Center Colocation Market | Covid19 Impact Analysis | Business Outlook, Grow …
Large enterprises are currently the larger users of colocation services, on account of their desire to decrease their operational expenses and increase focus on their more-critical areas. This is being done by giving the responsibility to house their expensive information technology (IT) hardware, such as routers, modems, and servers, to data centers, which also let them store huge amounts of data. Get the Sample Copy of this Report at:https://www.psmarketresearch.com/market-analysis/data-center-colocation-market/report-sample In addition, as
How Surging Interaction Through Enterprise Messaging Applications Driving Key Ma …
In the wake of the rising cyber attacks, adoption of cloud technologies, and focus on digital transformation, the need to meet the associated regulatory compliance is increasing around the world. Health Insurance Portability and Accountability Act (HIPAA), Payment Card Industry Data Security Standard (PCI DSS), General Data Protection Regulation (GDPR), and Federal Information Security Management Act (FISMA) are the various acts and standards which govern cyber security. Get the Sample Copy
Digital Out of Home Market Growth Declines, However COVID-19 Pandemic May Bring …
Digital out of home or DOOH refers to digital media displayed in outdoors that is accessible to the public and used for advertising and marketing purposes. It is displayed via electronic displays in a variety of formats, excluding radio and TV advertising. It consists of digital billboards, out of home (OOH) displays, digital signages, LEDs, and screen technologies. Request Sample Copy of Report : https://www.psmarketresearch.com/market-analysis/digital-out-of-home-market/report-sample The digital out of home market is
Medical Device Outsourcing Market - Future Developments, Trends, and Opportunity …
The healthcare industry is witnessing rapid growth because of the surging prevalence of diseases all across the world. The medical industry does not only deal with drugs and therapy, but medical devices are an important part of it. Attributed to this, the medical devices industry is registering swift growth as well. In 2018, the global medical devices market attained a value of $425.5 billion and is predicted to reach $612.7

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Natural Cancer Treatment
Cancer is going to be the number one killer in the world beginning from the year 2010! Facts of Cancer Cancer is a group of over 100 diseases that cause the cells in your body to grow to an uncontrollable level, as their normal growth regulating mechanism experiences an imbalance due to numerous external and internal factors. Many of the reasons for this scenario to occur are still unknown to medical science. However,
Mesothelioma: The “Orphan” Cancer
Government funding remains elusive for deadly disease Newton, MA. Oct. 1st 2007. While Americans have long been romanced by campaigns for breast cancer and leukemia research, it may be some time before mesothelioma enjoys a stint in the spotlight. Despite the fact that over 2,500 cases of the disease are diagnosed in the U.S. each year—with as many or more dying from it—the need to develop effective treatments for mesothelioma victims